Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
No additional AE; the VARIVAX was involved in multiple temperature excursions beginning on 12/5/2024, and the product was administered to the patient involved on 1/9/2025; This spontaneous report was received from an Other health professional and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. Beginning on 05-DEC-2024, Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE) was involved in multiple temperature excursions. On 09-JAN-2025, the patient was vaccinated with the improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #Y015108, expiration date: 06-SEP-2026) 0.5 mL (0.5 mL / Two dose series) (route was not reported) with sterile diluent (MERCK STERILE DILUENT) for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).
Comments: Not Applicable
Sterile Diluent